James Jones - 13 Jun 2024 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
James Jones by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
13 Jun 2024
Net transactions value
+$691
Form type
4
Filing time
02 Jul 2024, 17:32:01 UTC
Previous filing
30 Jan 2025
Next filing
02 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $38 +25 +0.07% $1.52 33,432 13 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $72 +48 +0.14% $1.50 33,480 14 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $61.09 +41 +0.12% $1.49 33,521 17 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $64.37 +41 +0.12% $1.57 33,562 18 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $62.73 +41 +0.12% $1.53 33,603 20 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $61.09 +41 +0.12% $1.49 33,644 21 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $69.96 +44 +0.13% $1.59 33,688 24 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $67.76 +44 +0.13% $1.54 33,732 25 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $66 +44 +0.13% $1.50 33,776 26 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $66.88 +44 +0.13% $1.52 33,820 27 Jun 2024 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $61.5 +41 +0.12% $1.50 33,861 28 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.